Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Procedures Participants received subcutaneous semaglutide 2.4 mg or placebo once-weekly for 104 weeks, in addition to standard behavioral intervention, followed by 7 weeks without treatment
Abstract Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a chronic, debilitating disease characterised by a wide range of symptoms that severely impact all aspects of life
For most people, this occurs within 2-3 months
It can also be given monthly or every three months
Many notice improved focus and mental sharpness within the first week of treatment
US$ 27.54
US$ 24.43
US$ 28.28
